Sign in
4

Changes in Ownership

MYRIAD GENETICS INC Filed Acc 0001219036-21-000024

Chief Scientific Officer sold 80,000 shares at an average $35.32 ($2,825,600)

  • Chief Scientific Officer acquired 80,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LANCHBURY JERRY S · Chief Scientific Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-23 Exercise or conversion : show line 1 in the form +10,000 $27.07 $270,700 242,550 D
2021-08-23 Sale : show line 2 in the form −10,000 $35.57 $355,700 232,550 D
2021-08-23 Exercise or conversion : show line 3 in the form +40,000 $27.07 $1,082,800 272,550 D
2021-08-23 Sale : show line 4 in the form −40,000 $35.07 $1,402,800 232,550 D
2021-08-24 Exercise or conversion : show line 5 in the form +30,000 $27.07 $812,100 262,550 D
2021-08-24 Sale : show line 6 in the form −30,000 $35.57 $1,067,100 232,550 D
Open-market sales · 80,000 sh · avg $35.32 · $2,825,600

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-08-23 Exercise or conversion : show line 7 in the form Non-Qualified Stock Option (right to buy) −10,000 70,000 D
2021-08-23 Exercise or conversion : show line 8 in the form Non-Qualified Stock Option (right to buy) −40,000 30,000 D
2021-08-24 Exercise or conversion : show line 9 in the form Non-Qualified Stock Option (right to buy) −30,000 0 D
Loading xslF345X03/edgardoc.xml…